BPC-157 + TB-500

The advanced regeneration blend combines BPC-157 (10 mg) and TB-500 (10 mg) in a single vial for extended research protocols requiring higher total compound quantities. This double-dose combination supports longer-duration studies on tissue repair synergy, wound healing kinetics, and inflammatory modulation over multi-week experimental timelines. Both compounds have been individually verified for purity ≥99% and are co-lyophilized to ensure homogeneous reconstitution. The 10+10 mg format is particularly suited for chronic administration studies, multi-tissue injury models where simultaneous treatment of multiple sites is required, and dose-response characterization experiments where the optimal BPC-157:TB-500 ratio is being established. Research has also explored this combination's potential effects on scar tissue remodeling, tendon-bone junction healing, and cardiac tissue repair following ischemic events.